Wave Life Sciences Ltd. is an innovative clinical-stage biotechnology company headquartered in Singapore, focused on developing novel oligonucleotide therapeutics to address serious genetic disorders. Utilizing its proprietary PRISM platform, the company excels in the design and production of stereopure oligonucleotides, which enhance the precision of genetic interventions. Wave’s commitment to addressing unmet medical needs is reflected in its robust pipeline, underscoring its potential as a transformative leader in genetic medicine and its goal of improving patient outcomes on a global scale.
Click "Analyze" to generate stock analysis
WVE Price Trend and Signals
WVE Option Volumes & Open Interests (aggregated)
WVE Put Call Ratios and IV (aggregated)
WVE Financials
2025-10-29Bullishmacd_signal
Golden cross below zero detected.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.